Indivior Pharmaceuticals Inc
INDV
Rank in Stocks
#3880
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Share Price
$34.01
Last synced: 2026-10-19
Market Cap
$4.24B
Change (1 day)
4.81%
Change (1 year)
40.02%
Country
US
Trade Indivior Pharmaceuticals Inc (INDV)
Category
Healthcare
Revenue for Indivior Pharmaceuticals Inc (INDV)
Revenue in Jun 2026 TTM: $1.33B
According to Indivior Pharmaceuticals Inc latest financial reports the company's current revenue (TTM) is $1.33B. In 2023 the company made a revenue of $1.09B an increase over the revenue in the year 2022 that was $901.00M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Indivior Pharmaceuticals Inc from 2016 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.33B | 12.12% |
| 2024 | $1.19B | 8.69% |
| 2023 | $1.09B | 21.31% |
| 2022 | $901.00M | 13.91% |
| 2021 | $791.00M | 22.26% |
| 2020 | $647.00M | -17.58% |
| 2019 | $785.00M | -18.22% |
| 2018 | $959.92M | -16.39% |
| 2017 | $1.15B | 18.50% |
| 2016 | $968.89M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 396.37% |
IN
|
